Advertisement

Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe

Gilead Sciences' COVID-19 Treatment Earns Conditional Approval in Europe

The European Commission has granted conditional approval to Veklury, the antiviral known as remdesivir.